SCHEDULE: Vanguard Group Discloses 12.14% Stake in Kenvue Inc.
Beneficial Ownership Disclosure
The Vanguard Group has filed an amended Schedule 13G, revealing a beneficial ownership of 12.14% in Kenvue Inc.'s common stock as of June 30, 2025.
Summary
- The Vanguard Group reported beneficial ownership of 233,245,730 shares of Kenvue Inc. common stock.
- This aggregate amount represents 12.14% of Kenvue Inc.'s common stock class.
- Vanguard holds sole voting power over 0 shares and shared voting power over 2,284,446 shares.
- Vanguard possesses sole dispositive power over 223,757,686 shares and shared dispositive power over 9,488,044 shares.
- The filing is an Amendment No. 2, indicating a previous disclosure of ownership by The Vanguard Group.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Kenvue Inc.
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of beneficial ownership by an institutional investor, without expressing explicit positive or negative sentiment regarding the issuer's performance or prospects.
Positives
- The disclosure of a significant 12.14% stake by a major institutional investor like The Vanguard Group can signal confidence in Kenvue Inc.'s long-term prospects.
Negatives
- This filing is a factual disclosure of ownership and does not inherently contain negative information regarding Kenvue Inc.'s performance or outlook.
Risks
- This Schedule 13G filing primarily details beneficial ownership and does not outline specific risks related to Kenvue Inc.'s operations or financial health.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Kenvue Inc.'s future performance or outlook.
Industry Context
The disclosure of a significant stake by a major asset manager like Vanguard in Kenvue Inc., a prominent consumer health company, reflects ongoing institutional interest in the consumer staples and healthcare sectors. This type of passive investment is common for large index fund providers.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holding by The Vanguard Group may influence investor perception and confidence in Kenvue Inc.'s stock.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement, representing the reporting period end date for the beneficial ownership. |
| 07/29/2025 | Date the Schedule 13G Amendment No. 2 was signed by The Vanguard Group. |
Keywords
Kenvue Inc, Vanguard Group, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Schedule 13G, Equity Stake, Consumer Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.